159 related articles for article (PubMed ID: 18428054)
1. Renal cell carcinoma in a 33-year-old male with an unusual morphology and an aggressive clinical course: possible Xp11.2 translocation.
Armah HB; Parwani AV
Pathology; 2008 Apr; 40(3):306-8. PubMed ID: 18428054
[No Abstract] [Full Text] [Related]
2. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.
Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L
Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965
[TBL] [Abstract][Full Text] [Related]
3. Melanotic Xp11 translocation renal cancer: report of a case with a unique intratumoral sarcoid-like reaction.
Ritterhouse LL; Cykowski MD; Hassell LA; Slobodov G; Bane BL
Diagn Pathol; 2014 Apr; 9():81. PubMed ID: 24735727
[TBL] [Abstract][Full Text] [Related]
4. Unravelling the mysteries of Xp11.2 translocation-associated renal cell carcinoma: A case report with a review of the literature.
Suneel R; Gupta P; Sekar A; Gupta N; Saxena A
Cytopathology; 2023 Jul; 34(4):367-376. PubMed ID: 37118914
[TBL] [Abstract][Full Text] [Related]
5. Cytopathology of Xp11 translocation renal cell carcinoma: a report of 5 cases.
Jin M; Parwani A; Li Z; Wakely PE
J Am Soc Cytopathol; 2020; 9(2):95-102. PubMed ID: 32029406
[TBL] [Abstract][Full Text] [Related]
6. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas.
Mosquera JM; Dal Cin P; Mertz KD; Perner S; Davis IJ; Fisher DE; Rubin MA; Hirsch MS
Diagn Mol Pathol; 2011 Sep; 20(3):129-37. PubMed ID: 21817901
[TBL] [Abstract][Full Text] [Related]
7. An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report.
Yu L; Li J; Xu S; Navia Miranda M; Wang G; Duan Y
Diagn Pathol; 2016 Oct; 11(1):98. PubMed ID: 27733182
[TBL] [Abstract][Full Text] [Related]
8. Xp11.2 translocation renal neoplasm with features of TFE3 rearrangement associated renal cell carcinoma and Xp11 translocation renal mesenchymal tumor with melanocytic differentiation harboring NONO-TFE3 fusion gene.
Yu W; Wang Y; Rao Q; Jiang Y; Zhang W; Li Y
Pathol Res Pract; 2019 Sep; 215(9):152521. PubMed ID: 31277953
[TBL] [Abstract][Full Text] [Related]
9. A novel partner of TFE3 in the Xp11 translocation renal cell carcinoma: clinicopathological analyses and detection of EWSR1-TFE3 fusion.
Fukuda H; Kato I; Furuya M; Tanaka R; Takagi T; Kondo T; Nagashima Y
Virchows Arch; 2019 Mar; 474(3):389-393. PubMed ID: 30552521
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma associated with Xp11.2 translocation arising in a horseshoe kidney.
Driss M; Boukadi A; Charfi L; Douira W; Mrad K; Bellagha I; Chaouachi B; Ben Romdhane K
Pathology; 2009; 41(6):587-90. PubMed ID: 19900111
[No Abstract] [Full Text] [Related]
11. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
Argani P; Olgac S; Tickoo SK; Goldfischer M; Moch H; Chan DY; Eble JN; Bonsib SM; Jimeno M; Lloreta J; Billis A; Hicks J; De Marzo AM; Reuter VE; Ladanyi M
Am J Surg Pathol; 2007 Aug; 31(8):1149-60. PubMed ID: 17667536
[TBL] [Abstract][Full Text] [Related]
12. An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man.
Koie T; Yoneyama T; Hashimoto Y; Kamimura N; Kusumi T; Kijima H; Ohyama C
Int J Urol; 2009 Mar; 16(3):333-5. PubMed ID: 19298350
[TBL] [Abstract][Full Text] [Related]
13. Kidney carcinoma associated with Xp11.2 translocation / TFE3 (ASPL-TFE3) gene fusion.
Salles PG; Soto M
Int Braz J Urol; 2005; 31(3):251-4. PubMed ID: 15992428
[TBL] [Abstract][Full Text] [Related]
14. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
Green WM; Yonescu R; Morsberger L; Morris K; Netto GJ; Epstein JI; Illei PB; Allaf M; Ladanyi M; Griffin CA; Argani P
Am J Surg Pathol; 2013 Aug; 37(8):1150-63. PubMed ID: 23715164
[TBL] [Abstract][Full Text] [Related]
15. A rare case of TFE-related pigmented renal tumor with overlapping features between melanotic Xp11 translocation renal cancer and Xp11 renal cell carcinoma with melanotic features.
Cardili L; Wrublevsky Pereira G; Viana CR
Pathol Int; 2017 Apr; 67(4):208-213. PubMed ID: 28208226
[TBL] [Abstract][Full Text] [Related]
16. Cyto-histological correlation of Xp11.2 translocation/TFE3 gene fusion associated renal cell carcinoma: Report of a case with review of literature.
Manucha V; Sessums MT; Lewin J; Akhtar I
Diagn Cytopathol; 2018 Mar; 46(3):267-270. PubMed ID: 29024535
[TBL] [Abstract][Full Text] [Related]
17. Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 gene fusion: an adult case report and literature review.
Wang Y; Wang Y; Feng M; Lian X; Lei Y; Zhou H
J Int Med Res; 2020 Oct; 48(10):300060520942095. PubMed ID: 33026261
[TBL] [Abstract][Full Text] [Related]
18. Melanotic Xp11/TFE3 translocation perivascular epithelioid cell tumor of the kidney in an 11-year-old female.
Ma Y; Feng J; Tian F; Ding D; Zhao J
Pediatr Blood Cancer; 2023 Jan; 70(1):e29843. PubMed ID: 35695480
[No Abstract] [Full Text] [Related]
19. TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.
Argani P; Zhong M; Reuter VE; Fallon JT; Epstein JI; Netto GJ; Antonescu CR
Am J Surg Pathol; 2016 Jun; 40(6):723-37. PubMed ID: 26975036
[TBL] [Abstract][Full Text] [Related]
20. Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis.
Klatte T; Streubel B; Wrba F; Remzi M; Krammer B; de Martino M; Waldert M; Marberger M; Susani M; Haitel A
Am J Clin Pathol; 2012 May; 137(5):761-8. PubMed ID: 22523215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
